Jubilant Pharma Singapore Announces Sale of 25.8% Stake in Sofie Biosciences and Subsequent Merger, with Potential $139.4 Million Proceeds Jubilant Pharma Singapore Announces Sale of 25.8% Stake in Sofie Biosciences and Subsequent Merger, with Potential $139.4 Million Proceeds By bigbreakingwire on 28/01/2024
